Ciloxan Side Effects

Generic Name: ciprofloxacin ophthalmic

Note: This page contains information about the side effects of ciprofloxacin ophthalmic. Some of the dosage forms included on this document may not apply to the brand name Ciloxan.

Not all side effects for Ciloxan may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

For the Consumer

Applies to ciprofloxacin ophthalmic: ophthalmic ointment, ophthalmic solution

Along with its needed effects, ciprofloxacin ophthalmic (the active ingredient contained in Ciloxan) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur while taking ciprofloxacin ophthalmic:

  • Allergic reaction, such as skin rash, hives, or itching
  • blurred vision or other change in vision
  • eye pain
  • irritation (severe) or redness of eye
  • nausea

Some side effects of ciprofloxacin ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common
  • Burning or other discomfort of eye
  • crusting or crystals in corner of eye
Less common
  • Bad taste following use in the eye
  • feeling of something in eye
  • itching of eye
  • redness of the lining of the eyelids
  • Dryness of eye
  • increased sensitivity of eyes to light
  • swelling of eyelid
  • tearing of eye

For Healthcare Professionals

Applies to ciprofloxacin ophthalmic: ophthalmic ointment, ophthalmic solution


Ocular side effects have most frequently included local burning or discomfort. In addition, white crystalline precipitates formed in the corneal defect of 17% of patients using ciprofloxacin ophthalmic (the active ingredient contained in Ciloxan) solution and 13% of patients using ciprofloxacin ophthalmic ointment for corneal ulcers. Lid margin crusting, crystal or scale formation in the eye, foreign body sensation, itching, corneal hyperemia, and a bad taste following instillation of the medication has occurred in less than 10% of patients. Less than 1% of patients reported corneal staining, keratopathy, keratitis, allergic reactions, lid edema, tearing, photophobia, corneal infiltrates, decreased vision, blurred vision, dry eye, epitheliopathy, eye pain or eye irritation.

Older patients (>50 years) have a greater risk of developing a corneal precipitate, possibly due to dryer eyes or alkaline eye surfaces. The precipitate does not appear to affect ciprofloxacin's antimicrobial efficacy but may prolong epithelial healing in patients with keratitis.


Hypersensitivity has been reported in less than 1% of patients.


Dermatologic side effects have included dermatitis (<1%).


Gastrointestinal side effects have included nausea (<1%).


Psychiatric side effects have included a case of acute psychosis (visual and auditory hallucinations, irrational speech, and behavioral disturbances) following ocular administration. The symptoms resolved upon discontinuation.

Nervous system

Nervous system side effects have included dizziness and lightheadedness following ocular administration.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.